Citius Oncology (CTOR) Long-Term Deferred Tax (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Long-Term Deferred Tax of $169252.0 for Q1 2026, down 97.75% quarter-over-quarter from $7.5 million in Q3 2024.
Citius Oncology (CTOR) Long-Term Deferred Tax (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Long-Term Deferred Tax for 3 consecutive years, with $169252.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $169252.0; the TTM figure through Mar 2026 stood at $169252.0 (changed N/A YoY), while the FY2024 annual figure was $7.5 million, up 62.07% from the prior year.
- Long-Term Deferred Tax eased to $169252.0 in Q1 2026 per CTOR's latest filing, from $7.5 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $7.5 million in Q3 2024 and bottomed at $169252.0 in Q1 2026.
- Historically, Long-Term Deferred Tax has averaged $4.1 million across 3 years, with a median of $4.6 million in 2023.
- On a YoY basis, Long-Term Deferred Tax climbed as much as 62.07% in 2024 and fell as far as 62.07% in 2024.
- Citius Oncology's Long-Term Deferred Tax stood at $4.6 million in 2023, then surged by 62.07% to $7.5 million in 2024, then sank by 97.75% to $169252.0 in 2026.
- Business Quant data shows CTOR's Long-Term Deferred Tax at $169252.0 in Q1 2026, $7.5 million in Q3 2024, and $4.6 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,252.00 |
| Sep 30, 2024 | 7.53 Mn |
| Sep 30, 2023 | 4.65 Mn |